"""""""""" O
The O
production O
of O
the O
drug O
is O
therefore O
no O
longer O
dependent O
on O
obtaining O
the O
active O
ingredient O
from O
plants O
, O
"""""""""" O
says O
Peter O
Seeberger O
. O

Synthesis O
from O
a O
by O
product O
of O
artemisinin O
production O
As O
a O
starting O
point O
, O
the O
chemists O
use O
artemisinic O
acid O
"""""""""" O
a O
substance O
produced O
as O
a O
hitherto O
unused O
by O
product O
from O
the O
isolation O
of O
artemisinin O
from O
sweet O
wormwood O
, O
which O
is O
produced O
in O
volumes O
ten O
times O
greater O
than O
the O
active O
ingredient O
itself O
. O

Moreover O
, O
artemisinic O
acid O
can O
easily O
be O
produced O
in O
genetically O
modified O
yeast O
as O
it O
has O
a O
much O
simpler O
structure O
. O

"""""""""" O
We O
convert O
the O
artemisinic O
acid O
into O
artemisinin O
in O
a O
single O
step O
, O
"""""""""" O
says O
Peter O
Seeberger O
. O

"""""""""" O
And O
we O
have O
developed O
a O
simple O
apparatus O
for O
this O
process O
, O
which O
enables O
the O
production O
of O
large O
volumes O
of O
the O
substance O
under O
very O
controlled O
conditions O
. O

"""""""""" O
The O
only O
reaction O
sequence O
known O
up O
to O
now O
required O
several O
steps O
, O
following O
each O
of O
which O
the O
intermediate O
products O
had O
to O
be O
isolated O
laboriously O
"""""""""" O
a O
method O
that O
was O
far O
too O
expensive O
to O
offer O
as O
a O
viable O
alternative O
to O
the O
production O
of O
the O
drug O
from O
plants O
. O

The O
striking O
simplification O
of O
artemisinin O
synthesis O
required O
not O
only O
a O
keen O
sense O
for O
an O
elegant O
combination O
of O
the O
correct O
partial O
reactions O
to O
enable O
the O
process O
to O
take O
place O
in O
a O
single O
step O
; O
it O
also O
took O
a O
degree O
of O
courage O
, O
as O
the O
chemists O
departed O
from O
the O
paths O
typically O
taken O
by O
industry O
up O
to O
now O
. O

The O
effect O
of O
the O
molecule O
, O
which O
not O
only O
targets O
malaria B-DIS
but O
possibly O
also O
other O
infections O
and O
even O
breast O
cancer O
, O
is O
due O
to O
, O
among O
other O
things O
, O
a O
very O
reactive O
chemical O
group O
formed O
by O
two O
neighbouring O
oxygen O
atoms O
вЂ O
“ O
which O
chemists O
refer O
to O
as O
an O
endoperoxide O
. O

Peter O
Seeberger O
and O
FranГ§ois O
LГ O
© O
vesque O
use O
photochemistry O
to O
incorporate O
this O
structural O
element O
into O
the O
artemisinic O
acid O
. O

Ultraviolet O
light O
converts O
oxygen O
into O
a O
form O
that O
can O
react O
with O
molecules O
to O
form O
peroxides O
. O

800 O
photoreactors O
should O
suffice O
to O
cover O
the O
global O
requirement O
for O
artemisinin O
"""""""""" O
Photochemistry O
is O
a O
simple O
and O
cost O
effective O
method O
. O

However O
, O
the O
pharmaceutical O
industry O
has O
not O
used O
it O
to O
date O
because O
it O
was O
so O
difficult O
to O
control O
and O
implement O
on O
a O
large O
scale O
, O
"""""""""" O
explains O
Peter O
Seeberger O
. O

In O
the O
large O
reaction O
vessels O
with O
which O
industrial O
manufacturers O
work O
, O
flashes O
of O
light O
do O
not O
penetrate O
deeply O
enough O
from O
outside O
and O
the O
reactive O
form O
of O
oxygen O
is O
not O
produced O
in O
sufficient O
volumes O
. O

The O
Potsdam O
based O
scientists O
have O
succeeded O
in O
resolving O
this O
problem O
using O
an O
ingenious O
trick O
: O
They O
channel O
the O
reaction O
mixture O
containing O
all O
of O
the O
required O
ingredients O
through O
a O
thin O
tube O
that O
they O
have O
wrapped O
around O
a O
UV O
lamp O
. O

In O
this O
structure O
, O
the O
light O
penetrates O
the O
entire O
reaction O
medium O
and O
triggers O
the O
chemical O
conversion O
process O
with O
optimum O
efficiency O
. O

"""""""""" O
The O
fact O
that O
we O
do O
not O
carry O
out O
the O
synthesis O
as O
a O
one O
pot O
reaction O
in O
a O
single O
vessel O
, O
but O
in O
a O
continuous O
flow O
reactor O
enables O
us O
to O
define O
the O
reaction O
conditions O
down O
to O
the O
last O
detail O
, O
"""""""""" O
explains O
Peter O
Seeberger O
. O

After O
just O
four O
and O
a O
half O
minutes O
a O
solution O
flows O
out O
of O
the O
tube O
, O
in O
which O
40 O
percent O
of O
the O
artemisinic O
acid O
has O
become O
artemisinin O
. O

"""""""""" O
We O
assume O
that O
800 O
of O
our O
simple O
photoreactors O
would O
suffice O
to O
cover O
the O
global O
requirement O
for O
artemisinin O
, O
"""""""""" O
says O
Peter O
Seeberger O
. O

And O
it O
could O
all O
happen O
very O
quickly O
. O

Peter O
Seeberger O
estimates O
that O
the O
innovative O
synthesis O
process O
could O
be O
ready O
for O
technical O
use O
in O
a O
matter O
of O
six O
months O
. O

This O
would O
alleviate O
the O
global O
shortage O
of O
artemisinin O
and O
exert O
considerable O
downward O
pressure O
on O
the O
price O
of O
the O
associated O
drugs O
. O

Norovirus B-DIS
closes O
five O
wards O
at O
L&D O
; O
Published O
on O
Tuesday O
17 O
January O
2012 O
10:43 O
PATIENTS O
at O
the O
Luton B-LOC
and O
Dunstable B-LOC
Hospital O
have O
been O
struck O
with O
the O
winter O
vomiting O
disease O
, O
Norovirus B-DIS
. O

Five O
wards O
at O
the O
hospital O
are O
closed O
so O
far O
, O
and O
they O
are O
all O
elderly O
medical O
wards O
. O

Visitors O
are O
banned O
from O
wards O
except O
for O
where O
the O
patient O
is O
critically O
ill O
, O
for O
example O
in O
the O
Intensive O
Care O
Unit O
. O

An O
L&D O
; O
spokesperson O
said O
: O
“ O
The O
L&D O
; O
has O
several O
cases O
of O
winter O
vomiting O
disease O
( O
norovirus B-DIS
) O
. O

In O
order O
to O
protect O
our O
patients O
, O
and O
members O
of O
the O
public O
, O
we O
are O
closing O
hospital O
wards O
to O
all O
visitors O
( O
with O
some O
exceptions O
) O
. O

“ O
Additionally O
we O
are O
asking O
the O
public O
only O
to O
come O
to O
A&E O
; O
if O
it O
is O
a O
real O
emergency O
, O
and O
if O
people O
do O
need O
to O
come O
to O
A&E O
; O
please O
don’t O
bring O
the O
whole O
family O
just O
one O
person O
to O
accompany O
the O
patient O
. O

“ O
These O
measures O
are O
necessary O
to O
protect O
our O
patients O
and O
public O
from O
the O
highly O
contagious O
norovirus B-DIS
which O
causes O
projectile O
vomiting O
and O
uncontrollable O
diarrhoea O
. O
” O
The O
ban O
on O
visitors O
is O
expected O
to O
last O
for O
24 O
48 O
hours O
. O

The O
spokesperson O
said O
if O
members O
of O
the O
public O
think O
they O
may O
have O
winter O
vomiting O
disease O
, O
they O
should O
not O
go O
to O
A&E O
; O
as O
there O
is O
no O
treatment O
for O
this O
virus O
, O
it O
needs O
to O
run O
its O
course O
over O
two O
or O
three O
days O
. O

The O
best O
advice O
is O
stay O
indoors O
, O
isolate O
yourself O
from O
other O
people O
and O
drink O
lots O
of O
water O
to O
keep O
rehydrated O
. O

For O
further O
advice O
call O
NHS O
Direct O
0845 O
4647 O
. O

Dengue B-DIS
: O
Paediatricians O
College O
warn O
parents O
As O
the O
spectre O
of O
a O
dengue B-DIS
epidemic O
loomed O
large O
, O
the O
Sri B-LOC
Lanka I-LOC
College O
of O
Paediatricians O
warned O
parents O
and O
doctors O
not O
to O
give O
children O
common O
pain O
relieving O
medication O
. O

The O
Health O
Ministry O
’s O
Epidemiology O
Unit O
reported O
that O
within O
the O
first O
13 O
days O
of O
this O
year O
, O
there O
were O
as O
many O
as O
674 O
dengue B-DIS
patients O
hospitalised O
with O
five O
deaths O
across O
the O
country O
. O

In O
this O
backdrop O
, O
the O
Sri B-LOC
Lanka I-LOC
College O
of O
Paediatricians O
has O
identified O
certain O
medications O
as O
being O
harmful O
and O
leading O
to O
bleeding O
in O
children O
. O

The O
overcrowded O
children O
’s O
ward O
at O
Colombo O
South O
hospital O
. O

Pic O
Saman O
Kariyawasam O
Non O
steroidal O
anti O
inflammatory O
drugs O
( O
NSAIDs O
) O
such O
as O
aspirin O
, O
ibuprofen O
, O
mefenamic O
acid O
and O
diclofenac O
sodium O
suppositories O
should O
not O
be O
given O
to O
children O
with O
fever O
prior O
to O
admission O
to O
hospital O
, O
urged O
Prof O
. O
Asvini O
Fernando O
, O
President O
of O
the O
Sri B-LOC
Lanka I-LOC
College O
of O
Paediatricians O
, O
pointing O
out O
that O
it O
is O
advisable O
to O
use O
only O
paracetamol O
at O
the O
recommended O
doses O
to O
bring O
down O
the O
fever O
, O
along O
with O
sponging O
the O
child O
with O
lukewarm O
water O
. O

In O
a O
formal O
message O
to O
all O
parents O
, O
the O
College O
of O
Paediatricians O
said O
, O
“ O
it O
is O
well O
documented O
that O
children O
who O
have O
had O
these O
medicines O
have O
a O
greater O
potential O
to O
bleed O
when O
they O
have O
Dengue B-DIS
Haemorrhagic I-DIS
Fever I-DIS
( O
DHF B-DIS
) O
” O
and O
advised O
parents O
to O
refrain O
from O
giving O
their O
children O
these O
medications O
if O
they O
have O
fever O
. O

Explaining O
that O
paediatric O
wards O
in O
most O
parts O
of O
the O
country O
are O
dealing O
with O
a O
large O
number O
of O
children O
with O
Dengue B-DIS
Fever I-DIS
( O
DF B-DIS
) O
and O
Dengue B-DIS
Haemorrhagic I-DIS
Fever I-DIS
( O
DHF B-DIS
) O
, O
Prof O
. O
Fernando O
said O
it O
had O
been O
noted O
that O
some O
of O
these O
children O
had O
received O
these O
medications O
before O
admission O
to O
hospital O
. O

These O
drugs O
( O
NSAIDs O
) O
are O
available O
in O
the O
market O
under O
different O
trade O
names O
. O

Hence O
it O
is O
important O
to O
check O
the O
labels O
of O
all O
medications O
available O
for O
control O
of O
fever O
, O
prior O
to O
giving O
them O
to O
your O
child O
, O
she O
said O
. O

Echoing O
the O
views O
of O
the O
paediatricians O
, O
an O
Epidemiology O
Unit O
official O
said O
parents O
should O
not O
panic O
and O
dose O
the O
child O
with O
these O
common O
pain O
relieving O
drugs O
. O

“ O
It O
is O
essential O
to O
rule O
out O
dengue B-DIS
whenever O
a O
child O
has O
fever O
, O
” O
the O
official O
said O
, O
explaining O
that O
the O
fever O
is O
only O
a O
symptom O
of O
the O
disease O
. O

Referring O
to O
the O
harmful O
effects O
of O
giving O
pain O
relieving O
drugs O
if O
the O
child O
is O
having O
dengue B-DIS
, O
the O
official O
said O
such O
drugs O
might O
erode O
the O
lining O
of O
the O
stomach O
. O

By O
nature O
, O
these O
medications O
also O
have O
anti O
clotting O
properties O
. O

As O
such O
NSAIDs O
in O
any O
form O
, O
be O
it O
tablets O
, O
liquids O
, O
suppositories O
or O
injections O
, O
should O
not O
be O
given O
for O
fever O
as O
dengue B-DIS
is O
raising O
its O
head O
once O
again O
, O
the O
official O
said O
. O

Meanwhile O
, O
senior O
Consultant O
Paediatrician O
, O
Dr O
. O
LakKumar O
Fernando O
who O
is O
also O
a O
dengue B-DIS
specialist O
said O
that O
looking O
at O
the O
trend O
last O
year O
, O
usually O
among O
those O
affected O
by O
dengue B-DIS
about O
50 O
% O
would O
be O
children O
. O

Last O
year O
, O
among O
the O
dengue B-DIS
deaths O
, O
one O
third O
comprised O
children O
and O
two O
third O
adults O
. O

Adding O
his O
voice O
to O
the O
serious O
concerns O
expressed O
over O
the O
use O
of O
NSAIDs O
when O
dengue B-DIS
is O
rampant O
, O
he O
pointed O
out O
that O
the O
guidelines O
for O
dengue B-DIS
management O
formally O
introduced O
by O
the O
Health O
Ministry O
in O
December O
2010 O
specifically O
advised O
against O
their O
use O
. O

If O
any O
child O
has O
fever O
, O
the O
first O
assumption O
should O
be O
that O
it O
is O
dengue B-DIS
, O
as O
this O
viral O
disease O
is O
now O
hyper O
endemic O
in O
Sri B-LOC
Lanka I-LOC
, O
he O
says O
. O

A O
few O
years O
ago O
if O
we O
saw O
10 O
children O
with O
fever O
, O
about O
2 O
3 O
would O
be O
dengue B-DIS
patients O
. O

But O
now O
in O
Colombo B-LOC
, O
of O
10 O
children O
with O
fever O
, O
we O
should O
suspect O
that O
five O
have O
dengue B-DIS
, O
while O
in O
Negombo B-LOC
it O
would O
be O
as O
high O
as O
eight O
, O
said O
Dr O
. O
Fernando O
who O
is O
based O
in O
Negombo B-LOC
. O

Being O
part O
of O
a O
team O
which O
has O
studied O
dengue B-DIS
management O
not O
only O
in O
Thailand O
but O
also O
helped O
implement O
such O
measures O
in O
Pakistan O
recently O
, O
he O
said O
that O
when O
called O
upon O
to O
advise O
paediatricians O
all O
over O
the O
country O
on O
managing O
very O
ill O
children O
he O
had O
come O
across O
many O
who O
had O
bled O
due O
to O
being O
given O
either O
ibuprofen O
or O
mefenamic O
acid O
before O
admission O
to O
hospital O
. O

“ O
When O
dengue B-DIS
is O
around O
us O
, O
don’t O
give O
NSAIDs O
to O
bring O
down O
the O
fever O
, O
” O
he O
said O
, O
even O
though O
fever O
could O
be O
a O
distressing O
symptom O
and O
parents O
may O
look O
for O
quick O
relief O
. O

For O
, O
NSAIDs O
would O
then O
do O
more O
harm O
than O
good O
. O

Explaining O
that O
dengue B-DIS
patients O
die O
due O
to O
prolonged O
shock O
, O
fluid O
overload O
or O
massive O
bleeding O
, O
Dr O
. O
Fernando O
added O
the O
cause O
of O
death O
in O
a O
large O
proportion O
of O
patients O
was O
massive O
bleeding O
. O

Currently O
while O
the O
Colombo B-LOC
and O
Gampaha B-LOC
districts O
of O
the O
Western O
Province O
are O
the O
worst O
hit O
with O
dengue B-DIS
, O
increased O
numbers O
are O
also O
being O
recorded O
in O
Kandy B-LOC
, O
Puttalam B-LOC
, O
Batticaloa B-LOC
, O
Kurunegala B-LOC
and O
Galle B-LOC
, O
the O
Sunday O
Times O
learns O
. O

Last O
week O
, O
the O
Sunday O
Times O
reported O
( O
city O
edition O
) O
that O
Negombo B-LOC
was O
in O
the O
throes O
of O
a O
dengue B-DIS
epidemic O
with O
at O
least O
75 O
patients O
, O
both O
children O
and O
adults O
, O
being O
treated O
at O
the O
Negombo B-LOC
Hospital O
on O
any O
given O
day O
. O

Malaria B-DIS
blamed O
for O
655,000 O
deaths O
in O
2010 O
GENEVA B-LOC
: O
Malaria B-DIS
caused O
the O
death O
of O
an O
estimated O
655,000 O
people O
last O
year O
, O
with O
86 O
percent O
of O
victims O
children O
aged O
under O
five O
, O
World O
Health O
Organisation O
figures O
showed O
on O
Tuesday O
. O

The O
figure O
marked O
a O
five O
percent O
drop O
in O
deaths O
from O
2009 O
. O

Africa O
accounted O
for O
91 O
percent O
of O
deaths O
and O
81 O
percent O
of O
the O
216 O
million O
cases O
worldwide B-LOC
in O
2010 O
. O

In O
its O
annual O
World O
Malaria B-DIS
Report O
for O
2011 O
, O
the O
WHO O
hailed O
as O
a O
"""""""""" O
major O
achievement O
"""""""""" O
a O
26 O
percent O
fall O
in O
mortality O
rates O
since O
2000 O
despite O
being O
well O
short O
of O
its O
50 O
percent O
target O
. O

The O
UN O
health O
agency O
aims O
to O
eradicate O
malaria B-DIS
deaths O
altogether O
by O
the O
end O
of O
2015 O
and O
reduce O
the O
number O
of O
cases O
by O
75 O
percent O
on O
2000 O
levels O
. O

International O
funding O
for O
the O
fight O
against O
malaria B-DIS
peaked O
at O
$ O
2 O
billion O
( O
1 O
. O
5 O
billion O
euros O
) O
this O
year O
but O
the O
WHO O
estimates O
$ O
5 O
billion O
will O
be O
needed O
each O
year O
until O
2015 O
if O
its O
targets O
are O
to O
be O
reached O
. O

The O
cash O
has O
funded O
an O
big O
increase O
in O
the O
number O
of O
households O
with O
insecticide O
treated O
mosquito O
nets O
, O
particularly O
in O
sub O
Saharan O
Africa O
where O
50 O
percent O
now O
have O
the O
nets O
compared O
with O
just O
three O
percent O
in O
2000 O
. O

To O
finance O
the O
fight O
, O
the O
WHO O
suggested O
a O
tax O
on O
financial O
transactions O
or O
the O
rolling O
out O
of O
a O
tax O
on O
airline O
journeys O
which O
it O
said O
, O
if O
extended O
to O
other O
countries O
, O
could O
generate O
significant O
extra O
funds O
. O

"""""""""" O
Other O
country O
specific O
schemes O
, O
such O
as O
tourist O
taxes O
, O
may O
offer O
opportunities O
to O
raise O
funds O
for O
control O
programmes O
in O
malaria B-DIS
endemic O
countries O
, O
"""""""""" O
the O
report O
said O
. O

WHO O
director O
general O
Margaret O
Chan O
welcomed O
the O
"""""""""" O
significant O
and O
durable O
"""""""""" O
progress O
in O
the O
fight O
against O
malaria B-DIS
but O
said O
parasite O
resistance O
to O
drugs O
was O
causing O
concern O
in O
parts O
of O
South O
east O
Asia O
. O

"""""""""" O
Parasite O
resistance O
to O
antimalarial O
medicines O
remains O
a O
real O
and O
ever O
present O
danger O
to O
our O
continued O
success O
, O
"""""""""" O
said O
Chan O
. O

"""""""""" O
There O
is O
an O
urgent O
need O
to O
develop O
an O
Asia O
wide O
framework O
to O
ensure O
sustained O
and O
coordinated O
action O
against O
this O
public O
health O
threat O
. O
"""""""""" O

According O
to O
the O
WHO O
, O
malaria B-DIS
is O
endemic O
in O
106 O
countries O
and O
is O
currently O
transmitted O
in O
99 O
of O
them O
. O

Of O
the O
99 O
, O
43 O
recorded O
a O
fall O
in O
reported O
cases O
of O
more O
than O
50 O
percent O
between O
2000 O
and O
2010 O
. O

Six O
countries O
account O
for O
60 O
percent O
of O
deaths O
from O
Malaria B-DIS
: O
Nigeria O
, O
Democratic O
Republic O
of O
Congo O
, O
Burkino O
Faso O
, O
Mozambique O
, O
Ivory O
Coast O
and O
Mali O
. O

Europe O
had O
an O
estimated O
176 O
cases O
of O
malaria B-DIS
in O
2010 O
with O
no O
reported O
deaths O
. O

Poultry O
exports O
hit O
after O
flu B-DIS
outbreak O
in O
Odhisa B-LOC
, O
Meghalaya B-LOC
KOCHI O
/ O
CHANDIGARH O
: O
Poultry O
companies O
are O
exercising O
caution O
with O
the O
outbreak O
of O
bird B-DIS
flu I-DIS
in O
parts O
of O
Odisha B-LOC
and O
Meghalaya B-LOC
, O
though O
they O
think O
it O
could O
be O
temporary O
and O
may O
not O
spread O
to O
other O
regions O
. O

But O
egg O
exporters O
aren O
' O
t O
lucky O
thanks O
to O
an O
export O
ban O
in O
place O
for O
the O
next O
six O
months O
. O

Bird O
cull O
which O
began O
in O
the O
two O
states O
is O
expected O
to O
carry O
on O
for O
a O
few O
days O
. O

The O
two O
states O
have O
put O
a O
quarantine O
procedure O
in O
place O
. O

Coimbatore O
based O
Suguna O
Poultry O
, O
which O
has O
a O
market O
share O
of O
15 O
% O
in O
the O
Rs O
600 O
crore O
poultry O
industry O
of O
Odisha B-LOC
, O
is O
watching O
the O
situation O
. O

Sales O
have O
not O
been O
impacted O
yet O
. O

"""""""""" O
Our O
business O
is O
concentrated O
in O
Cuttack O
and O
Bhubaneswar O
, O
where O
the O
flu B-DIS
has O
not O
spread O
so O
far O
, O
"""""""""" O
said O
B O
Soundararajan O
, O
managing O
director O
of O
Suguna O
Poultry O
Farms O
. O

Its O
supply O
to O
Meghalaya B-LOC
from O
its O
unit O
in O
Assam O
too O
hasn O
' O
t O
been O
affected O
. O

Suguna O
is O
India B-LOC
' O
s O
largest O
broiler O
chicken O
producer O
with O
about O
70 O
lakh O
birds O
and O
claims O
to O
be O
the O
world O
' O
s O
10th O
biggest O
. O

Andhra O
Pradesh O
, O
a O
major O
supplier O
of O
poultry O
products O
to O
Odisha B-LOC
, O
has O
seen O
a O
slowdown O
in O
sales O
. O

"""""""""" O
We O
sell O
about O
3 O
lakh O
hatching O
eggs O
and O
chicks O
to O
Odisha B-LOC
. O

This O
has O
been O
hit O
, O
"""""""""" O
said O
Ram O
Reddy O
, O
president O
of O
Andhra O
Pradesh O
Poultry O
Breeders O
Association O
. O

Venkateshwara O
Hatcheries O
, O
which O
has O
a O
good O
presence O
in O
the O
Northeastern O
states O
, O
has O
stopped O
supplies O
as O
a O
precautionary O
measure O
. O

"""""""""" O
We O
sell O
around O
40,000 O
eggs O
a O
day O
to O
parts O
of O
the O
Northeast O
, O
of O
which O
Meghalaya B-LOC
accounts O
for O
around O
15 O
% O
. O

At O
the O
outbreak O
of O
the O
bird B-DIS
flu B-DIS
, O
we O
have O
stopped O
our O
supplies O
for O
the O
time O
being O
, O
"""""""""" O
said O
T O
Venkateshwara O
Rao O
, O
a O
director O
with O
the O
company O
. O

The O
regions O
bordering O
Bangladesh B-LOC
have O
been O
susceptible O
to O
avian B-DIS
flu I-DIS
. O

"""""""""" O
In O
the O
past O
seven O
months O
, O
poultry O
exports O
from O
India B-LOC
have O
been O
banned O
due O
to O
the O
outbreak O
of O
bird B-DIS
flu I-DIS
in O
West B-LOC
Bengal I-LOC
and O
the O
Northeast O
. O

We O
were O
just O
receiving O
export O
orders O
from O
Middle O
East O
countries O
when O
the O
Indian O
government O
confirmed O
bird B-DIS
flu I-DIS
. O

Exports O
will O
not O
be O
allowed O
now O
, O
"""""""""" O
said O
Poultry O
Federation O
of O
India B-LOC
president O
Satish O
Pal O
. O

India B-LOC
export O
poultry O
products O
to O
the O
Middle O
East O
and O
Saarc O
countries O
from O
Andhra O
Pradesh O
, O
Karnataka O
and O
Maharashtra O
. O

The O
irritating O
truth O
about O
bowel B-DIS
disease I-DIS
Inflammatory B-DIS
bowel B-DIS
disease I-DIS
patient O
Mark O
Rievaj O
, O
left O
, O
is O
pictured O
with O
Dr O
Gil O
Kaplan O
at O
Alberta O
Health O
Sciences O
Centre O
Wednesday O
. O

CALGARY B-LOC
Elite O
speedskater O
Mark O
Rievaj O
had O
the O
Olympics O
in O
his O
sights O
10 O
years O
ago O
when O
he O
received O
a O
diagnosis O
that O
sent O
him O
to O
the O
sidelines O
. O

The O
young O
man O
from O
Calgary B-LOC
was O
diagnosed O
with O
Crohn B-DIS
' I-DIS
s I-DIS
disease I-DIS
, O
one O
of O
a O
group O
of O
inflammatory B-DIS
bowel B-DIS
ailments I-DIS
on O
the O
rise O
in O
Canada B-LOC
. O

The O
symptoms O
forced O
Rievaj O
to O
hang O
up O
his O
skates O
. O

Today O
, O
he O
' O
s O
also O
plagued O
by O
arthritis B-DIS
and O
mobility O
issues O
in O
his O
knees O
due O
to O
the O
disease O
, O
which O
has O
no O
cure O
. O

It O
' O
s O
a O
plight O
that O
University O
of O
Calgary B-LOC
faculty O
of O
medicine O
gastrointestinal O
specialist O
Dr O
. O
Gil O
Kaplan O
is O
studying O
closely O
. O

Kaplan O
, O
an O
Alberta O
Innovates O
health O
investigator O
, O
was O
part O
of O
a O
team O
that O
published O
a O
study O
this O
month O
in O
the O
journal O
Gastroenterology O
exploring O
the O
link O
between O
genetics O
, O
environmental O
factors O
such O
as O
diet O
and O
pollution O
, O
and O
inflammatory B-DIS
bowel B-DIS
disease I-DIS
( O
IBD B-DIS
) O
. O

The O
researchers O
combed O
through O
thousands O
of O
international O
research O
reports O
from O
the O
past O
50 O
years O
. O

They O
found O
that O
not O
only O
are O
cases O
of O
the O
disease O
on O
the O
rise O
, O
Canada B-LOC
has O
one O
of O
the O
highest O
rates O
in O
the O
world O
. O

The O
disease O
is O
more O
predominant O
in O
industrialized O
nations O
, O
including O
the O
United B-LOC
States I-LOC
and O
United B-LOC
Kingdom I-LOC
, O
and O
rates O
are O
now O
climbing O
in O
India B-LOC
and O
China B-LOC
, O
Kaplan O
said O
. O

"""""""""" O
The O
fascinating O
part O
about O
that O
is O
it O
starts O
to O
give O
us O
some O
clues O
about O
the O
environmental O
risk O
factors O
that O
might O
increase O
the O
risk O
of O
developing O
these O
diseases O
, O
"""""""""" O
he O
said O
. O

Genetics O
can O
make O
a O
person O
more O
susceptible O
to O
the O
ailment O
, O
but O
other O
factors O
including O
a O
fast O
food O
diet O
and O
increasingly O
sterile O
environments O
could O
be O
behind O
the O
growing O
number O
of O
patients O
, O
said O
Kaplan O
. O

Today O
' O
s O
era O
of O
antibacterial O
wipes O
and O
overall O
improved O
attention O
to O
cleanliness O
have O
helped O
eradicate O
some O
infectious O
diseases O
, O
but O
may O
also O
mean O
immune O
systems O
aren O
' O
t O
primed O
the O
same O
way O
they O
were O
decades O
ago O
, O
Kaplan O
explained O
. O

Diets O
in O
industrialized O
nations O
include O
more O
refined O
sugars O
and O
processed O
foods O
, O
and O
less O
vegetables O
and O
fibre O
another O
risk O
factor O
for O
IBD B-DIS
. O

Kaplan O
said O
he O
hopes O
the O
research O
will O
build O
a O
solid O
foundation O
for O
developing O
better O
ways O
to O
treat O
the O
disease O
. O

It O
' O
s O
a O
goal O
Rievaj O
hopes O
is O
realized O
in O
his O
lifetime O
. O

Rievaj O
was O
part O
of O
a O
speedskating O
group O
aiming O
to O
make O
the O
national O
team O
and O
try O
out O
for O
the O
Olympics O
when O
he O
was O
diagnosed O
. O

He O
tried O
to O
resume O
training O
, O
but O
eventually O
had O
to O
give O
up O
the O
sport O
to O
try O
to O
control O
symptoms O
of O
the O
disease O
, O
which O
most O
often O
strikes O
young O
adults O
. O

"""""""""" O
A O
lot O
of O
it O
is O
just O
crossing O
your O
fingers O
hoping O
you O
get O
the O
least O
of O
them O
or O
as O
little O
as O
possible O
, O
"""""""""" O
said O
Rievaj O
, O
32 O
. O

India B-LOC
' O
s O
polio B-DIS
victory O
fuels O
vaccine O
talks O
Published O
January O
12 O
, O
2012 O
When O
the O
clocks O
strike O
midnight O
in O
New B-LOC
Delhi I-LOC
on O
January O
12 O
, O
India B-LOC
will O
mark O
the O
first O
year O
in O
history O
it O
has O
recorded O
no O
new O
cases O
of O
polio B-DIS
. O

It O
' O
s O
a O
huge O
milestone O
for O
a O
country O
many O
experts O
thought O
would O
be O
the O
last O
place O
on O
earth O
to O
get O
rid O
of O
the O
crippling O
virus O
. O

And O
it O
' O
s O
an O
exciting O
step O
forward O
for O
global O
health O
workers O
battling O
to O
make O
polio B-DIS
only O
the O
second O
human O
infectious O
disease O
after O
smallpox O
to O
be O
eradicated O
. O

"""""""""" O
If O
all O
the O
data O
comes O
in O
clear O
over O
the O
next O
few O
weeks O
, O
then O
India B-LOC
, O
for O
the O
first O
time O
, O
will O
show O
up O
as O
an O
unshaded O
area O
on O
WHO O
polio B-DIS
maps O
, O
"""""""""" O
said O
Sona O
Bari O
of O
the O
World O
Health O
Organisation O
' O
s O
( O
WHO O
) O
Global O
Polio B-DIS
Eradication O
Initiative O
. O

"""""""""" O
This O
is O
a O
great O
start O
to O
the O
year O
for O
India B-LOC
. O
"""""""""" O

But O
while O
India B-LOC
celebrates O
, O
global O
health O
authorities O
are O
debating O
how O
to O
reduce O
the O
risk O
that O
vaccines O
containing O
live O
viruses O
may O
reintroduce O
the O
disease O
to O
places O
only O
just O
becoming O
polio B-DIS
free O
. O

It O
' O
s O
a O
tricky O
judgment O
of O
timing O
, O
risk O
and O
cost O
, O
but O
the O
fact O
it O
' O
s O
being O
discussed O
is O
a O
sign O
of O
how O
far O
the O
polio B-DIS
fight O
has O
come O
. O

CRIPPLING O
DISEASE O
A O
disease O
that O
until O
the O
1950s O
also O
crippled O
thousands O
every O
year O
in O
rich O
nations O
, O
polio B-DIS
attacks O
the O
nervous O
system O
and O
can O
cause O
irreversible O
paralysis O
within O
hours O
of O
infection O
. O

It O
often O
spreads O
in O
areas O
with O
poor O
sanitation O
a O
factor O
that O
helped O
it O
keep O
a O
grip O
on O
India B-LOC
for O
many O
decades O
and O
children O
under O
five O
are O
the O
most O
vulnerable O
. O

But O
it O
can O
be O
stopped O
with O
comprehensive O
, O
population O
wide O
vaccination O
. O

The O
WHO O
has O
certified O
polio B-DIS
vaccines O
made O
by O
GlaxoSmithKline O
, O
Novartis O
, O
Sanofi O
Aventis O
, O
Panacea O
Biotec O
and O
others O
for O
use O
in O
immunization O
campaigns O
. O

India B-LOC
' O
s O
success O
leaves O
just O
three O
countries O
Pakistan O
, O
Afghanistan O
and O
Nigeria O
where O
polio B-DIS
is O
still O
endemic O
, O
and O
sets O
an O
example O
for O
what O
could O
be O
in O
store O
for O
them O
. O

"""""""""" O
It O
shows O
we O
' O
re O
going O
to O
get O
it O
done O
elsewhere O
, O
"""""""""" O
said O
John O
Hewko O
, O
chief O
executive O
and O
president O
of O
the O
charity O
Rotary O
International O
, O
which O
has O
spearheaded O
the O
global O
fight O
against O
polio B-DIS
for O
three O
decades O
. O

Since O
the O
Global O
Polio B-DIS
Eradication O
Initiative O
was O
launched O
in O
1988 O
, O
there O
has O
been O
a O
99 O
percent O
reduction O
in O
polio B-DIS
cases O
worldwide O
. O

Back O
then O
the O
disease O
was O
endemic O
in O
125 O
countries O
and O
caused O
paralysis O
in O
nearly O
1,000 O
children O
every O
day O
. O

By O
contrast O
, O
in O
the O
whole O
of O
2011 O
, O
there O
were O
only O
620 O
new O
cases O
worldwide O
. O

Experts O
are O
under O
no O
illusion O
that O
getting O
the O
three O
remaining O
endemic O
countries O
to O
India B-LOC
' O
s O
zero O
level O
is O
a O
challenge O
that O
will O
not O
be O
overcome O
for O
several O
more O
years O
. O

But O
as O
the O
prospect O
of O
global O
eradication O
comes O
into O
sight O
, O
it O
brings O
a O
new O
dilemma O
that O
will O
be O
a O
focus O
of O
the O
WHO O
' O
s O
executive O
board O
next O
week O
. O

LIVE O
OR O
INACTIVATED O
At O
the O
heart O
of O
the O
issue O
are O
oral O
polio B-DIS
vaccines O
, O
which O
are O
highly O
effective O
and O
owe O
much O
of O
their O
success O
to O
the O
fact O
they O
are O
cheap O
, O
easy O
to O
deliver O
and O
contain O
live O
polio B-DIS
virus O
strains O
. O

Because O
type O
2 O
has O
already O
been O
eliminated O
, O
a O
three O
strain O
oral O
vaccine O
called O
tOPV O
is O
being O
phased O
out O
in O
favour O
of O
a O
bivalent O
or O
two O
strain O
one O
called O
bOPV O
which O
fights O
type O
1 O
and O
type O
3 O
. O

But O
the O
problem O
remains O
that O
the O
viruses O
are O
live O
. O

"""""""""" O
Looking O
to O
the O
future O
we O
clearly O
want O
to O
get O
away O
from O
using O
oral O
polio B-DIS
vaccine O
( O
OPV O
) O
altogether O
because O
with O
OPV O
we O
continue O
to O
be O
putting O
live O
viruses O
into O
people O
and O
into O
the O
environment O
, O
"""""""""" O
said O
David O
Salisbury O
, O
chair O
of O
the O
WHO O
' O
s O
European O
Certification O
Commission O
for O
Polio B-DIS
Eradication O
and O
Britain O
' O
s O
director O
of O
immunization O
. O

Bari O
described O
it O
as O
a O
tipping O
point O
. O

"""""""""" O
When O
the O
risks O
from O
the O
vaccine O
start O
to O
outweigh O
the O
risks O
from O
the O
wild O
virus O
, O
that O
' O
s O
when O
we O
should O
make O
the O
decision O
, O
"""""""""" O
she O
said O
. O

There O
is O
an O
alternative O
called O
inactivated O
polio B-DIS
vaccine O
or O
IPV O
, O
but O
unlike O
OPV O
it O
' O
s O
expensive O
to O
make O
and O
difficult O
to O
deliver O
because O
it O
has O
to O
be O
injected O
by O
trained O
health O
workers O
in O
clinics O
. O

Most O
wealthy O
countries O
, O
like O
the O
United O
States O
and O
Britain O
, O
dealt O
with O
the O
issue O
by O
using O
oral O
polio B-DIS
vaccines O
to O
stop O
transmission O
and O
maintain O
that O
halt O
, O
then O
switching O
to O
inactivated O
polio B-DIS
vaccines O
when O
they O
were O
sure O
they O
had O
the O
virus O
beaten O
, O
Bari O
said O
. O

For O
poorer O
countries O
with O
limited O
health O
services O
, O
infrastructure O
and O
resources O
, O
that O
won O
' O
t O
be O
so O
easy O
, O
so O
research O
teams O
are O
looking O
at O
ways O
of O
trying O
to O
make O
IPV O
more O
accessible O
. O

One O
option O
is O
to O
lower O
the O
amount O
of O
antigen O
needed O
in O
the O
vaccine O
by O
adding O
an O
adjuvant O
, O
or O
booster O
, O
that O
would O
be O
cheaper O
. O

Another O
might O
be O
developing O
a O
way O
of O
injecting O
only O
into O
the O
skin O
, O
rather O
than O
under O
it O
, O
a O
method O
that O
would O
require O
a O
lower O
and O
therefore O
cheaper O
IPV O
dose O
. O

IMMEDIATE O
TASK O
Salisbury O
stressed O
the O
decision O
to O
switch O
the O
vaccine O
is O
something O
for O
the O
future O
, O
and O
halting O
polio B-DIS
transmission O
worldwide O
is O
still O
the O
most O
pressing O
task O
. O

"""""""""" O
These O
will O
be O
very O
difficult O
judgments O
but O
we O
' O
ve O
got O
to O
start O
discussing O
them O
now O
. O

If O
we O
didn O
' O
t O
we O
' O
d O
be O
criticized O
in O
future O
for O
not O
having O
thought O
things O
through O
, O
"""""""""" O
he O
said O
. O

India B-LOC
' O
s O
success O
came O
only O
after O
a O
massive O
, O
$ O
2 O
billion O
battle O
mostly O
financed O
domestically O
. O

In O
the O
last O
year O
alone O
, O
there O
were O
two O
separate O
nationwide O
immunization O
programs O
, O
each O
of O
which O
immunized O
172 O
million O
children O
under O
the O
age O
of O
five O
over O
five O
days O
. O

To O
reach O
people O
on O
the O
move O
, O
mobile O
vaccination O
teams O
were O
sent O
out O
immunize O
children O
at O
railway O
stations O
, O
on O
trains O
, O
and O
at O
bus O
stands O
, O
market O
places O
and O
construction O
sites O
. O

The O
country O
' O
s O
lone O
case O
last O
calendar O
year O
was O
on O
January O
13 O
in O
a O
two O
year O
old O
girl O
in O
Howrah O
, O
close O
to O
Kolkata O
in O
West O
Bengal O
. O

"""""""""" O
The O
evidence O
from O
India B-LOC
is O
if O
you O
do O
the O
job O
well O
, O
you O
stop O
polio B-DIS
, O
"""""""""" O
Salisbury O
said O
. O

"""""""""" O
And O
if O
it O
can O
be O
done O
in O
India B-LOC
, O
technically O
it O
can O
be O
done O
anywhere O
. O
"""""""""" O

Flu B-DIS
shot O
still O
available O
to O
residents O
: O
government O
Published O
on O
January O
17 O
, O
2012 O
The O
seasonal O
influenza B-DIS
vaccination O
is O
still O
available O
throughout O
the O
province O
, O
the O
Department O
of O
Health O
and O
Community O
Services O
reminded O
the O
public O
today O
. O

The O
flu B-DIS
shot O
can O
be O
obtained O
through O
a O
family O
physician O
or O
a O
public O
health O
office O
. O

“ O
We O
are O
beginning O
to O
see O
some O
initial O
confirmed O
cases O
of O
influenza B-DIS
B I-DIS
in O
the O
province O
, O
” O
said O
Dr O
. O

Faith O
Stratton O
, O
Chief O
Medical O
Officer O
of O
Health O
for O
Newfoundland B-LOC
and I-LOC
Labrador I-LOC
. O

“ O
While O
the O
number O
of O
cases O
is O
low O
and O
symptoms O
are O
mild O
, O
receiving O
the O
seasonal O
flu B-DIS
shot O
, O
along O
with O
practising O
regular O
hand O
washing O
, O
is O
the O
most O
effective O
way O
to O
protect O
against O
influenza B-DIS
viruses O
. O
” O
The O
influenza O
vaccine O
is O
provided O
at O
no O
cost O
for O
individuals O
at O
high O
risk O
for O
complications O
from O
influenza B-DIS
, O
including O
: O
• O
Adults O
and O
children O
with O
chronic O
conditions O
requiring O
regular O
medical O
or O
hospital O
care O
such O
as O
respiratory O
disorders O
, O
cardiac O
disease O
, O
renal O
disease O
, O
metabolic O
disorders O
and O
mobility O
impairment O
; O
• O
Persons O
in O
residential O
care O
, O
including O
residents O
and O
staff O
; O
• O
Persons O
age O
60 O
and O
over O
; O
• O
Children O
age O
six O
months O
to O
23 O
months O
; O
• O
Health O
care O
workers O
including O
those O
in O
the O
community O
or O
chronic O
care O
facilities O
; O
• O
Essential O
service O
workers O
( O
e O
. O
g O
. O

police O
, O
ambulance O
, O
firefighters O
) O
; O
• O
Aboriginal O
people O
; O
• O
Household O
contacts O
of O
people O
at O
high O
risk O
of O
influenza B-DIS
complications O
; O
• O
Pregnant O
women O
; O
and O
, O
• O
Poultry O
and O
swine O
industry O
workers O
. O

“ O
Although O
the O
flu B-DIS
season O
often O
begins O
in O
the O
fall O
, O
Newfoundland B-LOC
and I-LOC
Labrador B-LOC
is O
now O
reporting O
its O
first O
cases O
, O
” O
Stratton O
said O
. O

“ O
Flu B-DIS
symptoms O
include O
rapid O
onset O
of O
cough O
, O
fever O
, O
headache O
, O
chills O
and O
general O
body O
aches O
and O
pains O
. O
” O
Individuals O
are O
encouraged O
to O
practise O
the O
three O
principles O
of O
personal O
hygiene O
, O
Clean O
, O
Cover O
and O
Contain O
, O
to O
help O
prevent O
the O
spread O
of O
influenza B-DIS
. O

It O
is O
recommended O
to O
practise O
thorough O
hand O
washing O
, O
cover O
coughs O
and O
sneezes O
, O
and O
to O
stay O
home O
when O
sick O
. O

